Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1986 1
1989 1
1992 3
1993 2
1994 2
1995 1
1996 2
1997 3
1998 3
1999 1
2000 1
2001 2
2002 4
2004 4
2005 7
2006 5
2007 1
2008 5
2009 4
2010 10
2011 7
2012 8
2013 9
2014 16
2015 10
2016 13
2017 16
2018 24
2019 18
2020 16
2021 25
2022 31
2023 39
2024 35
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for mohamed bound
Search for Mohamed Bouni instead (1 results)
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
Elmunzer BJ, Foster LD, Serrano J, Coté GA, Edmundowicz SA, Wani S, Shah R, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Papachristou GI, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Petersen B, Wang AY, Saltzman JR, Spitzer RL, Ordiah C, Spino C, Durkalski-Mauldin V; SVI Study Group. Elmunzer BJ, et al. Lancet. 2024 Feb 3;403(10425):450-458. doi: 10.1016/S0140-6736(23)02356-5. Epub 2024 Jan 11. Lancet. 2024. PMID: 38219767 Free PMC article. Clinical Trial.
The primary outcome was post-ERCP pancreatitis. To declare non-inferiority, the upper bound of the two-sided 95% CI for the difference in post-ERCP pancreatitis (indomethacin alone minus indomethacin plus stent) would have to be less than 5% (non-inferiority margin) in bot …
The primary outcome was post-ERCP pancreatitis. To declare non-inferiority, the upper bound of the two-sided 95% CI for the differenc …
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.
Lee W, Ko SY, Mohamed MS, Kenny HA, Lengyel E, Naora H. Lee W, et al. J Exp Med. 2019 Jan 7;216(1):176-194. doi: 10.1084/jem.20181170. Epub 2018 Dec 19. J Exp Med. 2019. PMID: 30567719 Free PMC article.
NETs were detected in the omentum of ovarian tumor-bearing mice before metastasis and of women with early-stage ovarian cancer. NETs, in turn, bound ovarian cancer cells and promoted metastasis. Omental metastasis was decreased in mice with neutrophil-specific deficiency o …
NETs were detected in the omentum of ovarian tumor-bearing mice before metastasis and of women with early-stage ovarian cancer. NETs, in tur …
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS. Uddin MH, et al. Clin Transl Med. 2023 Dec;13(12):e1513. doi: 10.1002/ctm2.1513. Clin Transl Med. 2023. PMID: 38131168 Free PMC article.
BACKGROUND: The majority of pancreatic ductal adenocarcinoma (PDAC) patients experience disease progression while on treatment with gemcitabine and nanoparticle albumin-bound (nab)-paclitaxel (GemPac) necessitating the need for a more effective treatment strategy for this …
BACKGROUND: The majority of pancreatic ductal adenocarcinoma (PDAC) patients experience disease progression while on treatment with gemcitab …
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Structural advances in transcription elongation.
Mohamed AA, Vazquez Nunez R, Vos SM. Mohamed AA, et al. Curr Opin Struct Biol. 2022 Aug;75:102422. doi: 10.1016/j.sbi.2022.102422. Epub 2022 Jul 9. Curr Opin Struct Biol. 2022. PMID: 35816930 Free PMC article. Review.
Only recently, structures of transcription elongation complexes bound to key transcription elongation factors have been determined in bacterial and eukaryotic systems. ...
Only recently, structures of transcription elongation complexes bound to key transcription elongation factors have been determined in …
Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes.
Walters LC, Rozbesky D, Harlos K, Quastel M, Sun H, Springer S, Rambo RP, Mohammed F, Jones EY, McMichael AJ, Gillespie GM. Walters LC, et al. Cell Rep. 2022 Jun 14;39(11):110959. doi: 10.1016/j.celrep.2022.110959. Cell Rep. 2022. PMID: 35705051 Free PMC article.
For HLA-E-VL9, there is concordance between SAXS and crystal parameters. In contrast, HLA-E-bound pathogen-derived peptides produce larger SAXS dimensions that reduce to their crystallographic dimensions only when excess peptide is supplied. Further crystallographic analys …
For HLA-E-VL9, there is concordance between SAXS and crystal parameters. In contrast, HLA-E-bound pathogen-derived peptides produce l …
Osmosensing by WNK Kinases.
Akella R, Humphreys JM, Sekulski K, He H, Durbacz M, Chakravarthy S, Liwocha J, Mohammed ZJ, Brautigam CA, Goldsmith EJ. Akella R, et al. Mol Biol Cell. 2021 Aug 19;32(18):1614-1623. doi: 10.1091/mbc.E20-01-0089. Epub 2021 Mar 10. Mol Biol Cell. 2021. PMID: 33689398 Free PMC article.
An improved structure of the inactive kinase domain of WNK1, and a comparison with the structure of a monophosphorylated form of WNK1, suggests that large cavities, greater hydration, and specific bound water may participate in the osmosensing mechanism. Our prior work sho …
An improved structure of the inactive kinase domain of WNK1, and a comparison with the structure of a monophosphorylated form of WNK1, sugge …
Replication fork uncoupling causes nascent strand degradation and fork reversal.
Kavlashvili T, Liu W, Mohamed TM, Cortez D, Dewar JM. Kavlashvili T, et al. Nat Struct Mol Biol. 2023 Jan;30(1):115-124. doi: 10.1038/s41594-022-00871-y. Epub 2023 Jan 2. Nat Struct Mol Biol. 2023. PMID: 36593312 Free PMC article.
Notably, the replicative helicase remains bound during NSD and fork reversal. Unexpectedly, NSD occurs before and after fork reversal, indicating that multiple degradation steps take place. ...
Notably, the replicative helicase remains bound during NSD and fork reversal. Unexpectedly, NSD occurs before and after fork reversal …
Structural basis of adenylyl cyclase 9 activation.
Qi C, Lavriha P, Mehta V, Khanppnavar B, Mohammed I, Li Y, Lazaratos M, Schaefer JV, Dreier B, Plückthun A, Bondar AN, Dessauer CW, Korkhov VM. Qi C, et al. Nat Commun. 2022 Feb 24;13(1):1045. doi: 10.1038/s41467-022-28685-y. Nat Commun. 2022. PMID: 35210418 Free PMC article.
Adenylyl cyclase 9 (AC9) is a membrane-bound enzyme that converts ATP into cAMP. The enzyme is weakly activated by forskolin, fully activated by the G protein Galphas subunit and is autoinhibited by the AC9 C-terminus. ...Here, we present the cryo-EM structures of AC9 in s …
Adenylyl cyclase 9 (AC9) is a membrane-bound enzyme that converts ATP into cAMP. The enzyme is weakly activated by forskolin, fully a …
An oestrogen-receptor-alpha-bound human chromatin interactome.
Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EG, Huang PY, Welboren WJ, Han Y, Ooi HS, Ariyaratne PN, Vega VB, Luo Y, Tan PY, Choy PY, Wansa KD, Zhao B, Lim KS, Leow SC, Yow JS, Joseph R, Li H, Desai KV, Thomsen JS, Lee YK, Karuturi RK, Herve T, Bourque G, Stunnenberg HG, Ruan X, Cacheux-Rataboul V, Sung WK, Liu ET, Wei CL, Cheung E, Ruan Y. Fullwood MJ, et al. Nature. 2009 Nov 5;462(7269):58-64. doi: 10.1038/nature08497. Nature. 2009. PMID: 19890323 Free PMC article.
Here we describe the development of a new strategy, chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) for the de novo detection of global chromatin interactions, with which we have comprehensively mapped the chromatin interaction network bound by oestr …
Here we describe the development of a new strategy, chromatin interaction analysis by paired-end tag sequencing (ChIA-PET) for the de novo d …
318 results